Related Experiment Video
Updated: Apr 12, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Clinical Inquiry: Do statins increase the risk of developing diabetes?
Kristin Parker1, Karen Dohr, Jon O Neher
1Valley Family Medicine Residency, Renton, WA, USA.
Statin drug therapy slightly increases diabetes risk, with one extra case observed for every 255 patients over four years. This finding is crucial for understanding the benefits and risks of cholesterol-lowering medications.
Area of Science:
- Cardiovascular Medicine
- Endocrinology
- Pharmacology
Background:
- Statins are widely prescribed cholesterol-lowering drugs.
- Diabetes mellitus is a significant public health concern.
- Understanding drug-induced risks is essential for patient safety.
Purpose of the Study:
- To quantify the risk of new-onset diabetes associated with statin therapy.
- To provide data for informed clinical decision-making regarding statin use.
Main Methods:
- Meta-analysis of clinical trials evaluating statin therapy.
- Longitudinal follow-up of patient cohorts to identify incident diabetes cases.
Main Results:
- Statin therapy was associated with a small but statistically significant increase in diabetes incidence.
- An estimated one additional case of diabetes per 255 patients treated with statins over a 4-year period.
Conclusions:
- The benefits of statin therapy in cardiovascular risk reduction generally outweigh the small increased risk of diabetes.
- Clinicians and patients should consider this risk when initiating and managing statin treatment.
More Related Videos
08:45LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Oral Hypoglycemic Agents: Biguanides and Glitazones
Dipeptidyl Peptidase 4 Inhibitors
Diabetes Mellitus: Type 2 and Gestational
Cholesterol: Significance and Regulation
Considering cholesterol and...
Coronary Artery Disease I: Introduction